Breaking News Instant updates and real-time market news.

ALFA

Alfa Corporation

$51.99

0.58 (1.13%)

, ALSSF

Alsea

$0.00

(0.00%)

04:55
05/09/19
05/09
04:55
05/09/19
04:55

Credit Suisse to hold a conference

2019 Mexico Investment Ideas Conference will be held in Mexico City, Mexico on May 6-9.

ALFA

Alfa Corporation

$51.99

0.58 (1.13%)

ALSSF

Alsea

$0.00

(0.00%)

AMOV

America Movil, also tag AMX

$14.43

(0.00%)

EMBVF

Arca Continental

$0.00

(0.00%)

T

AT&T

$30.30

-0.22 (-0.72%)

GBOOF

Grupo Financiero Banorte

$0.00

(0.00%)

BBVA

Banco Bilbao

$5.79

0.035 (0.61%)

CMTOY

Cementos Argos

$0.00

(0.00%)

CX

Cemex

$4.51

-0.025 (-0.55%)

KOF

Coca-Cola Femsa

$63.17

-0.71 (-1.11%)

DISH

Dish

$34.94

0.35 (1.01%)

FCFS

First Cash Financial

$97.51

-1.81 (-1.82%)

TV

Televisa

$9.52

-0.075 (-0.78%)

PSMT

PriceSmart

$58.29

0.06 (0.10%)

MELI

MercadoLibre

$536.29

-2.9 (-0.54%)

KMB

Kimberly-Clark

$126.88

0.68 (0.54%)

  • 18

    May

  • 20

    May

  • 29

    May

  • 23

    Jul

  • 24

    Jul

  • 13

    Nov

ALFA Alfa Corporation
$51.99

0.58 (1.13%)

ALSSF Alsea
$0.00

(0.00%)

AMOV America Movil, also tag AMX
$14.43

(0.00%)

04/05/19
HSBC
04/05/19
UPGRADE
HSBC
Buy
America Movil upgraded to Buy from Hold at HSBC
03/07/19
BTGP
03/07/19
UPGRADE
BTGP
Buy
America Movil upgraded to Buy from Hold at BTG Pactual
04/05/19
JPMS
04/05/19
UPGRADE
Target $17
JPMS
Overweight
JPMorgan upgrades America Movil to Overweight with $17 target
JPMorgan analyst Andre Baggio upgraded America Movil to Overweight from Neutral and raised his price target for the shares to $17 from $16. The potential harm of anti-preponderance measures in Mexico, including further regulation and increasing competition, may have been overstated, Baggio tells investors in a research note. He believes America Movil has been "proving that it can adapt and cope with the tougher regulation." The analyst cites the "benign" competitive environment in Mexico as well as improving trends in Brazil for his upgrade of America Movil to Overweight.
04/05/19
JPMS
04/05/19
UPGRADE
Target $17
JPMS
Overweight
America Movil upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Andre Baggio upgraded America Movil to Overweight from Neutral and raised his price target for the shares to $17 from $16.
EMBVF Arca Continental
$0.00

(0.00%)

03/11/19
GSCO
03/11/19
UPGRADE
GSCO
Buy
Arca Continental upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Luca Cipiccia upgraded Arca Continental to Buy and raised his price target for the shares to MXN 143 from MXN 127. The analyst sees attractive valuations among Latin America Beverages ahead of an expected recovery.
06/18/18
JPMS
06/18/18
UPGRADE
JPMS
Overweight
Arca Continental upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Lucas Ferreira upgraded Arca Continental to Overweight with a price target of MXN 137.
T AT&T
$30.30

-0.22 (-0.72%)

03/29/19
03/29/19
UPGRADE
Target $35

Buy
Viacom upgraded to Buy at Loop Capital on de-risked AT&T loss
As previously reported, Loop Capital analyst Alan Gould upgraded Viacom (VIAB) to Buy from Hold with a price target of $35. The analyst cites the company's loss of its biggest distributor AT&T (T) having been de-risked which, he believes, raises the likelihood of a Viacom merger with CBS (CBS). Gould adds that despite the renewed distribution deal with AT&T, investors can accumulate shares at a lower price than a few weeks ago, resulting in a "positive risk-reward" for Viacom.
04/05/19
04/05/19
UPGRADE
Target $36

Outperform
Viacom upgraded to Outperform from Sector Perform at RBC Capital
As previously reported, RBC Capital analyst Steven Cahall upgraded Viacom (VIAB) to Outperform from Sector Perform and raised his price target to $36 from $31, saying the company's "less contentious" than feared DirecTV (T) deal improves its standing and "paves the way toward merger talks" with CBS (CBS). The analyst sees an implied upside for Viacom stock at over 30% on the CBS deal prospects and believes that investors should own both to hedge the exchange ratio risk of the potential transaction.
04/17/19
GSCO
04/17/19
NO CHANGE
GSCO
Sprint, T-Mobile headlines positive for Dish, Intelsat, says Goldman Sachs
Goldman Sachs analyst Brett Feldman, while taking no view on the outcome of the proposed merger between Sprint (S) and T-Mobile (TMUS), laid out his thoughts for other industry participants following the Wall Street Journal's report that the Department of Justice is unlikely to approve the deal as currently structured. The analyst believes investors will initially see the headlines as negative for the other major wireless carriers, namely AT&T (T) and Verizon (VZ), since they "create uncertainty over long-term industry structure." Further, investors will initially see these headlines as a slight positive for tower operators American Tower (AMT), Crown Castle (CCI) and SBA Communications (SBAC) as they "imply less risk of material cell site decommissioning," Feldman told investors earlier in a research note. The analyst also thinks investors will view the Journal's report as positive for owners of excess spectrum such as Dish (DISH) and Intelsat (I) and a slight positive for cable operators like Altice USA (ATUS), Charter (CHTR) and Comcast (CMCSA).
05/03/19
NRCS
05/03/19
UPGRADE
Target $70
NRCS
Buy
Northcoast upgrades Generac to Buy as emerging play on 5G growth
As previously reported, Northcoast analyst Tom Hayes upgraded Generac to Buy from Neutral as he sees significant benefits from its increased closing rates for home standby units and the backup power needs associated with 5G growth. Spending for the infrastructure for 5G is expected to ramp to $26B in 2022 and Generac has established relationships with Verizon (VZ), AT&T (T) and T-Mobile (TMUS), noted Hayes, who believes the company is likely used by the major carriers in a significant percentage of all their back-up power needs. He set a $70 price target on Generac shares.
GBOOF Grupo Financiero Banorte
$0.00

(0.00%)

09/26/18
LEHM
09/26/18
INITIATION
LEHM
Overweight
Grupo Financiero Banorte reinstated with an Overweight at Barclays
Barclays analyst Gilberto Garcia reinstated coverage of Grupo Financiero Banorte with an Overweight rating.
BBVA Banco Bilbao
$5.79

0.035 (0.61%)

01/15/19
HSBC
01/15/19
DOWNGRADE
HSBC
Hold
Banco Bilbao downgraded to Hold from Buy at HSBC
04/01/19
DBAB
04/01/19
UPGRADE
DBAB
Buy
Banco Bilbao upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Ignacio Ulargui upgraded Banco Bilbao Vizcaya Argentaria to Buy from Hold and raised his price target for the shares to EUR 6.00 from EUR 4.50. The analyst sees a positive potential impact for banks from the new administration in Mexico.
10/25/18
SBSH
10/25/18
UPGRADE
SBSH
Buy
Banco Bilbao upgraded to Buy from Neutral at Citi
Citi analyst Stefan Nedialkov upgraded Banco Bilbao Vizcaya Argentaria to Buy with a price target of EUR 5.75.
09/04/18
JPMS
09/04/18
DOWNGRADE
JPMS
Neutral
Banco Bilbao downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Kian Abouhossein downgraded Banco Bilbao Vizcaya Argentaria to Neutral and lowered his price target for the shares to EUR 6.80 from EUR 8. The analyst says the Turkish macro-economic outlook could be less favorable than he had initially anticipated. As such, he views BBVA as fairly valued relative to European bank peers.
CMTOY Cementos Argos
$0.00

(0.00%)

CX Cemex
$4.51

-0.025 (-0.55%)

04/29/19
MSCO
04/29/19
DOWNGRADE
MSCO
Equal Weight
Cemex downgraded to Equal Weight from Overweight at Morgan Stanley
10/29/18
SCOT
10/29/18
DOWNGRADE
SCOT
Sector Perform
Cemex downgraded to Sector Perform from Outperform at Scotiabank
11/14/18
UBSW
11/14/18
DOWNGRADE
UBSW
Neutral
Cemex downgraded to Neutral from Buy at UBS
04/10/19
GSCO
04/10/19
INITIATION
Target $5.5
GSCO
Neutral
Cemex initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Bruno Amorim initiated Cemex with a Neutral rating and $5.50 price target, calling the company "a successful but still ongoing turnaround story" impacted by a tough macro environment and trading at what he views as a fair valuation.
KOF Coca-Cola Femsa
$63.17

-0.71 (-1.11%)

04/03/19
SANT
04/03/19
DOWNGRADE
SANT
Hold
Coca-Cola Femsa downgraded to Hold from Buy at Santander
06/20/18
BBVA
06/20/18
UPGRADE
BBVA
Outperform
Coca-Cola Femsa upgraded to Outperform from Market Perform at BBVA
10/23/18
SANT
10/23/18
UPGRADE
SANT
Buy
Coca-Cola Femsa upgraded to Buy from Hold at Santander
10/02/18
UBSW
10/02/18
UPGRADE
UBSW
Buy
Coca-Cola Femsa upgraded to Buy from Neutral at UBS
DISH Dish
$34.94

0.35 (1.01%)

05/06/19
FBCO
05/06/19
UPGRADE
FBCO
Neutral
Dish upgraded to Neutral from Underperform at Credit Suisse
05/06/19
05/06/19
UPGRADE
Target $34

Neutral
Dish upgraded to Neutral at Credit Suisse on improving video subscriptions
As previously reported, Credit Suisse analyst Douglas Mitchelson upgraded Dish to Neutral from Underperform saying he finds that risk/reward and potential catalysts across wireless and Pay TV are now in balance. In particular, the analyst believes "video subscriber losses are at a nadir and likely to improve dramatically" in the second half of the year as programming dispute impacts expire, while the remaining subscriber base is longer-tenured, more rural, and thus lower churn. While pay TV financial results will likely be pressured all year, this pressure was already evident in Q1 results and improving subscriber losses will be considered a leading indicator, Mitchelson adds. He also raised his price target on the shares to $34 from $26.
05/06/19
05/06/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Sinclair Broadcast (SBGI) upgraded to Buy from Neutral at B. Riley FBR with analyst Barton Crockett saying yhe company's deal to acquire 21 regional sports networks from Disney (DIS) at valuation of $10.6B "looks like a home-run". 2. ImmunoGen (IMGN) upgraded to Buy from Neutral at H.C. Wainwright with analyst Debjit Chattopadhyay seeing 40% downside risk to the stock if the FDA does not consider mirvetuximab to be a clinically meaningful addition to the armametum against ovarian cancer versus a 145% upside potential. 3. Dish (DISH) upgraded to Neutral from Underperform at Credit Suisse with analyst Douglas Mitchelson saying he finds that risk/reward and potential catalysts across wireless and Pay TV are now in balance. 4. Post Holdings (POST) upgraded to Buy from Neutral at Goldman Sachs with analyst Jason English stating he views the recent pullback as a buying opportunity as he thinks transient headwinds were the reason results missed investor expectations in Q2. 5. Dentsply Sirona (XRAY) upgraded to Outperform from Market Perform at Barrington with analyst Michael Petusky saying the company's turnaround is "now on a firm, provable footing". This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
FCFS First Cash Financial
$97.51

-1.81 (-1.82%)

12/03/18
WEDB
12/03/18
DOWNGRADE
WEDB
Neutral
First Cash Financial downgraded to Neutral from Outperform at Wedbush
01/08/19
JEFF
01/08/19
DOWNGRADE
Target $5
JEFF
Hold
Jefferies downgrades Elevate Credit on lack of earnings visibility
Jefferies analyst John Hecht downgraded Elevate Credit (ELVT) to Hold from Buy and lowered his price target for the shares to $5 from $9.50. The analyst cites the company's credit issues and resulting lack of earnings visibility for the downgrade. He's becoming more selective on the Consumer Finance space and names his top picks as Aaron's (AAN), Enova International (ENVA), First Cash Financial (FCFS) and OneMain Holdings (OMF). Growth prospects remain solid for some and credit performance has been consistent for most, while the market appears to be pricing in an economic downturn, Hecht tells investors in a research note.
01/31/19
WEDB
01/31/19
NO CHANGE
Target $90
WEDB
Neutral
Wedbush sees First Cash Financial reporting EPS at upper end of guidance
Wedbush analyst Henry Coffey said that while First Cash Financial's guidance was disappointing, the outlook reflects a loss of 25c-30c per share associated with the closure of Ohio stores and the exit of consumer lending in other U.S. markets and the value he places on the contribution from consumer lending "is very low." While he had been expecting a slower exit from the Ohio pay day loan and installment loan products and less of a final hit to EPS, he also thinks moving away from this product makes sense for a number of reasons. Coffey, who believes First Cash will report EPS at the upper end of its guidance, keeps a Neutral rating and $90 price target on the stock.
10/26/18
WEDB
10/26/18
UPGRADE
WEDB
Outperform
First Cash Financial upgraded to Outperform from Neutral at Wedbush
TV Televisa
$9.52

-0.075 (-0.78%)

01/31/19
SBSH
01/31/19
UPGRADE
SBSH
Buy
Televisa upgraded to Buy from Neutral at Citi
01/23/19
SCOT
01/23/19
UPGRADE
SCOT
Sector Perform
Televisa upgraded to Sector Perform from Underperform at Scotiabank
12/26/18
IBBA
12/26/18
UPGRADE
IBBA
Outperform
Televisa upgraded to Outperform from Market Perform at Itau BBA
04/24/19
NWST
04/24/19
DOWNGRADE
NWST
Neutral
Televisa downgraded to Neutral from Buy at New Street
PSMT PriceSmart
$58.29

0.06 (0.10%)

MELI MercadoLibre
$536.29

-2.9 (-0.54%)

05/07/19
IBBA
05/07/19
DOWNGRADE
Target $520
IBBA
Underperform
MercadoLibre downgraded to Underperform from Outperform at Itau BBA
Itau BBA analyst Rodrigo Nistor double downgraded MercadoLibre to Underperform from Outperform while raising his price target for the shares to $520 from $400.
05/03/19
SUSQ
05/03/19
UPGRADE
SUSQ
Neutral
MercadoLibre upgraded to Neutral from Negative at Susquehanna
05/03/19
DBAB
05/03/19
UPGRADE
DBAB
Buy
MercadoLibre upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank upgraded MercadoLibre to Buy from Hold citing the company's "strong" Q1 results.
05/03/19
FBCO
05/03/19
NO CHANGE
Target $640
FBCO
Outperform
MercadoLibre price target raised to $640 from $520 at Credit Suisse
Credit Suisse analyst Stephen Ju maintained an Outperform rating on MercadoLibre and raised his price target to $640 from $520, saying the Q1 GMV shortfall did not filter through to a revenue miss.
KMB Kimberly-Clark
$126.88

0.68 (0.54%)

04/23/19
04/23/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst James Faucette citing his view that the market has "not yet fully appreciated" the impact of the company's settlement with Apple (AAPL), which he thinks not only increases earnings substantially while also expanding the freedom with which Qualcomm can pursue new opportunities. 2. Kimberly-Clark (KMB) upgraded to Buy from Hold at Argus and to Outperform from Neutral at Macquarie. 3. Sanderson Farms (SAFM) upgraded to Neutral from Sell at Goldman Sachs with analyst Adam Samuelson saying African swine fever is upending the protein markets, Samuelson tells investors in a research note. 4. Visteon (VC) upgraded to Outperform from Neutral at Baird while Veoneer (VNE) was upgraded to Neutral from Underperform. 5. Sony (SNE) upgraded to Outperform from Neutral at Macquarie. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/11/19
EXAN
02/11/19
UPGRADE
Target $67
EXAN
Neutral
Exane upgrades Colgate-Palmolive to Neutral, names Kimberly-Clark top pick
Exane BNP Paribas analyst Jeff Stent upgraded Colgate-Palmolive (CL) to Neutral from Underperform and raised his price target for the shares to $67 from $56. Investor interest in Colgate will continue to build with its organic sales growth trends set to improve and with a management change "seemingly close," Stent tells investors in a research note. The analyst also raised his price target for Procter & Gamble (PG) to $95 from $86 and keeps an Underperform rating on the name. The company's near-term organic growth has an "upside bias," but this is already reflect in the stock following the "recent meteoric re-rating," Stent contends. In taking his Home and Personal Care coverage to three stocks, the analyst today also initiated coverage of Kimberly-Clark (KMB) with an Outperform rating and $130 price target. Kimberly-Clark is Stent's preferred way to play the U.S. Home and Personal Care space. While the company faces structural challenges, "if ever there is a time to buy, it is now" as the input cost picture improves and industry pricing is "starting to kick in," he says.
04/23/19
MACQ
04/23/19
UPGRADE
MACQ
Outperform
Kimberly-Clark upgraded to Outperform from Neutral at Macquarie
04/23/19
ARGS
04/23/19
UPGRADE
ARGS
Buy
Kimberly-Clark upgraded to Buy from Hold at Argus

TODAY'S FREE FLY STORIES

LB

L Brands

$24.88

0.59 (2.43%)

10:59
05/23/19
05/23
10:59
05/23/19
10:59
On The Fly
Analysts remain cautious on L Brands despite stronger quarter »

Shares of L Brands (LB)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 22

    Aug

IDYA

IDEAYA Biosciences

$0.00

(0.00%)

10:57
05/23/19
05/23
10:57
05/23/19
10:57
Syndicate
Breaking Syndicate news story on IDEAYA Biosciences »

IDEAYA Biosciences opens…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

CNX

CNX Resources

$7.56

-0.26 (-3.32%)

10:50
05/23/19
05/23
10:50
05/23/19
10:50
Options
Size put option block in CNX after calls bought yesterday »

Size put option block in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

10:50
05/23/19
05/23
10:50
05/23/19
10:50
General news
Treasury Action: yields have extended lower as Wall Street sinks »

Treasury Action: yields…

AZZ

AZZ Inc.

$43.62

(0.00%)

10:46
05/23/19
05/23
10:46
05/23/19
10:46
Hot Stocks
AZZ Inc. discloses change in independent registered public accounting firm »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$39.97

-0.22 (-0.55%)

10:45
05/23/19
05/23
10:45
05/23/19
10:45
Hot Stocks
GSK to change sales representative incentive program »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

10:45
05/23/19
05/23
10:45
05/23/19
10:45
General news
he April U.S. new home sales report beat estimates »

The April U.S. new home…

10:45
05/23/19
05/23
10:45
05/23/19
10:45
General news
Kansas City Fed Manufacturing Index Level to be reported at 11:00 »

May Kansas City Fed…

10:45
05/23/19
05/23
10:45
05/23/19
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

10:45
05/23/19
05/23
10:45
05/23/19
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

RTLR

Rattler Midstream

$0.00

(0.00%)

10:43
05/23/19
05/23
10:43
05/23/19
10:43
Syndicate
Breaking Syndicate news story on Rattler Midstream »

Rattler Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

XLE

Energy Select Sector SPDR

$61.29

-2.23 (-3.51%)

10:40
05/23/19
05/23
10:40
05/23/19
10:40
Options
Massive ratio put spread in Energy SPDR ETF adjust profitable position »

Massive ratio put spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACAD

Acadia

$24.78

-0.33 (-1.31%)

, ALKS

Alkermes

$24.44

-0.61 (-2.44%)

10:39
05/23/19
05/23
10:39
05/23/19
10:39
Conference/Events
JPMorgan biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Fye,…

ACAD

Acadia

$24.78

-0.33 (-1.31%)

ALKS

Alkermes

$24.44

-0.61 (-2.44%)

ITCI

Intra-Cellular

$13.49

0.41 (3.13%)

NBIX

Neurocrine

$78.73

-1.14 (-1.43%)

SAGE

Sage Therapeutics

$173.51

-1.49 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 05

    Jun

  • 27

    Sep

IDYA

IDEAYA Biosciences

$0.00

(0.00%)

10:37
05/23/19
05/23
10:37
05/23/19
10:37
Syndicate
IDEAYA Biosciences indicated to open at $14, IPO priced at $10 »

IDEAYA Biosciences (IDYA)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

CZR

Caesars

$8.96

-0.155 (-1.70%)

10:35
05/23/19
05/23
10:35
05/23/19
10:35
Options
Caesars put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
05/23/19
05/23
10:30
05/23/19
10:30
General news
EIA natural gas storage change for week ending May 17 »

Gas inventories 100 Bcf…

RTLR

Rattler Midstream

$0.00

(0.00%)

10:25
05/23/19
05/23
10:25
05/23/19
10:25
Syndicate
Breaking Syndicate news story on Rattler Midstream »

Rattler Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

10:25
05/23/19
05/23
10:25
05/23/19
10:25
Conference/Events
JPMorgan TMT analyst to hold an Analyst/Industry conference call »

TMT Sector Specialist…

AGR

Avangrid

$50.37

-0.04 (-0.08%)

10:23
05/23/19
05/23
10:23
05/23/19
10:23
Hot Stocks
Avangrid Renewables announces new wind contract with Dairyland »

Dairyland Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

AMX

America Movil, also tag AMOV

$14.15

-0.19 (-1.33%)

10:20
05/23/19
05/23
10:20
05/23/19
10:20
Options
Call buyer opens a notable new position in American Movil »

Call buyer opens a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTLR

Rattler Midstream

$0.00

(0.00%)

, FANG

Diamondback Energy

$103.16

-5.71 (-5.24%)

10:19
05/23/19
05/23
10:19
05/23/19
10:19
Syndicate
Breaking Syndicate news story on Rattler Midstream, Diamondback Energy »

Rattler Midstream…

RTLR

Rattler Midstream

$0.00

(0.00%)

FANG

Diamondback Energy

$103.16

-5.71 (-5.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 23

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
05/23/19
05/23
10:17
05/23/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
05/23/19
05/23
10:16
05/23/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUNW

Sunworks

$0.68

0.0226 (3.42%)

10:15
05/23/19
05/23
10:15
05/23/19
10:15
Hot Stocks
Sunworks wins contract to build 1 MW solar project for California school »

Sunworks announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTLR

Rattler Midstream

$0.00

(0.00%)

, FANG

Diamondback Energy

$102.97

-5.9 (-5.42%)

10:15
05/23/19
05/23
10:15
05/23/19
10:15
Syndicate
Rattler Midstream indicated to open at $17.50, IPO priced at $17.50 »

Rattler Midstream (RTLR),…

RTLR

Rattler Midstream

$0.00

(0.00%)

FANG

Diamondback Energy

$102.97

-5.9 (-5.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 23

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.